ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication
PLOS Pathogens · 08.04.2025 · 21 (4) · e1012452
DOI: 10.1371/journal.ppat.1012452 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 08.04.2025. Verfasst von Adwait Parchure und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia. Hauptthemen laut MEDLINE: Adenosine Deaminase, Herpesvirus 1, Human, Virus Replication, eIF-2 Kinase. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Croatian Science Foundation, Italian Ministry of University and Research (MIUR), Research Foundation Flanders (FWO).
Abstract (Originalsprache)
Adenosine deaminase acting on dsRNA 1 (ADAR1) catalyzes the deamination of adenosines to inosines in double-stranded RNAs (dsRNA) and regulates innate immunity by preventing the hyperactivation of cytosolic dsRNA sensors such as MDA5, PKR or ZBP1. ADAR1 has been shown to exert pro- and antiviral, editing-dependent and editing-independent functions in viral infections, but little is known about its function in herpesvirus replication. We now demonstrate that herpes simplex virus 1 (HSV-1) hyperactivates PKR in the absence of ADAR1, resulting in eIF2α mediated translational arrest and reduced viral replication. Silencing of PKR or inhibition of its downstream effectors by viral (ICP34.5) or pharmacological (ISRIB) inhibitors rescues viral replication in ADAR1-deficient cells. Upon infection, ADAR1 p150 interacts with PKR and prevents its hyperactivation. Our findings demonstrate that ADAR1 is an important proviral factor that raises the activation threshold for sensors of innate immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Faculty of Biotechnology and Drug Development, University of Rijeka, Rijeka, Croatia.
- Department of Molecular Medicine and Biotechnology, Faculty of Medicine in Rijeka, University of Rijeka, Rijeka, Croatia.
- VIB-UGent Center for Inflammation Research, Ghent, Belgium.
- Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium.
- Department of Biology, University of Padova, Padova, Italy.
ORCID-Profile: Igor Jurak
Förderung
- Croatian Science Foundation
- Italian Ministry of University and Research (MIUR)
- Research Foundation Flanders (FWO)
- Hrvatska Zaklada za Znanost
- University of Rijeka
- European Regional Development Fund
- the Italian Ministry of University and Research
- Odysseus II Grant
Zitieren
APA
Parchure, A., Cesarec, M., Braut, A., Kolman, R., Ivanišević, V., Čunko, M., Bursać, S., de Reuver, R., Begonja, A. J., Rosani, U., Volarević, S., Maelfait, J., & Jurak, I. (2025). ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication. PLOS Pathogens, 21(4), e1012452. https://doi.org/10.1371/journal.ppat.1012452
Vancouver
Parchure A, Cesarec M, Braut A, Kolman R, Ivanišević V, Čunko M, et al. ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication. PLOS Pathogens. 2025;21(4):e1012452. doi:10.1371/journal.ppat.1012452
BibTeX
@article{Parchure2025,
author = {Parchure, Adwait and Cesarec, Mia and Braut, Antonija and Kolman, Robert and Ivanišević, Vlatka and Čunko, Marina and Bursać, Slađana and de Reuver, Richard and Begonja, Antonija J and Rosani, Umberto and Volarević, Siniša and Maelfait, Jonathan and Jurak, Igor},
title = {ADAR1 p150 prevents HSV-1 from triggering PKR/eIF2α-mediated translational arrest and is required for efficient viral replication},
journal = {PLOS Pathogens},
year = {2025},
volume = {21},
number = {4},
pages = {e1012452},
doi = {10.1371/journal.ppat.1012452}
}
EUVIMED